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Colony-stimulating factor 1 (CSF-1) is the main growth factor controlling the development of macrophages
from myeloid progenitor cells. However, CSF-1 also regulates some of the key effector functions of macrophages
(e.g., phagocytosis and cytokine secretion). The endosomal SNARE protein syntaxin 7 (Stx7) regulates vesicle
trafficking events involved in phagocytosis and cytokine secretion. Therefore, we investigated the ability of
CSF-1 to regulate Stx7. CSF-1 upregulated Stx7 expression in primary mouse macrophages; it also upregulated
expression of its SNARE partners Vti1b and VAMP8 but not Stx8. Additionally, CSF-1 induced the rapid serine
phosphorylation of Stx7 and enhanced its binding to Vti1b, Stx8, and VAMP8. Bioinformatics analysis and
results from experiments with kinase inhibitors suggested the CSF-1-induced phosphorylation of Stx7 was
mediated by protein kinase C and Akt in response to phosphatidylinositol 3-kinase activation. Based on
mutagenesis studies, CSF-1 appeared to increase the binding of Stx7 to its SNARE partners by inducing the
phosphorylation of serine residues in the Habc domain and/or “linker” region of Stx7. Thus, CSF-1 is a key
regulator of Stx7 expression and function in macrophages. Furthermore, the effects of CSF-1 on Stx7 may
provide a mechanism for the regulation of macrophage effector functions by CSF-1.
Macrophages are a key component of the immune system,
where they function as sentinels to detect pathogens (e.g.,
bacteria, viruses, and fungi) (18, 26). The phagocytosis and
intracellular killing of pathogens by macrophages play a central
role in host defense (19). Macrophages express a range of
receptors (e.g., Fc, complement, and scavenger receptors) that
enable them to phagocytose pathogens (1, 19, 51). The subse-
quent presentation of pathogen-derived peptides to T cells is
important for the development of acquired immunity (15, 33).
Additionally, the secretion of a range of cytokines (e.g., tumor
necrosis factor [TNF], interleukin 6 [IL-6], and IL-12) and
chemokines (e.g., CCL2 and CXCL8) by macrophages helps
orchestrate both the innate and adaptive immune responses to
infection (15, 18, 26).
The effector functions of macrophages are reliant upon the
coordinated trafficking of intracellular vesicles from one com-
partment to another (e.g., trafficking of cytokine-containing
vesicles from the endoplasmic reticulum to the plasma mem-
brane) and fusion between different vesicles (e.g., fusion of
phagosomes with lysosomes) (49). SNARE proteins are inti-
mately involved in intracellular vesicle trafficking (22, 25, 55).
They are a group of relatively small (15 to 40 kDa), largely
membrane-associated proteins that are characterized by a con-
served region of around 60 amino acids, referred to as a
SNARE domain, and typically a short C-terminal stretch of
hydrophobic residues that facilitates their anchoring to cellular
membranes. Generally, R-SNARE proteins are found on the
vesicle delivering the cargo, whereas Q-SNAREs are typically
anchored to the vesicle target membrane (e.g., plasma mem-
brane, phagosomal membrane, etc.). The docking and fusion
of transport vesicles with target membranes are mediated by
the direct interaction of R-SNAREs with Q-SNAREs to form
trans-SNARE complexes consisting of one R-SNARE protein
and two to three Q-SNARE proteins (22, 25, 55).
Although colony-stimulating factor 1 (CSF-1) is the main
growth factor governing the proliferation, differentiation, and sur-
vival of macrophages (48), it also modulates several macrophage
effector functions, including cytokine secretion, phagocytosis, and
macropinocytosis. For example, CSF-1 primes macrophages for
enhanced TNF, IL-6, and IL-12p40 secretion in response to lipo-
polysaccharide (LPS) (50). Conversely, pharmacologic inhibitors
of the CSF-1 receptor suppress the LPS-induced production of
these cytokines both in vitro (24) and in vivo (13). CSF-1 has also
been reported to enhance the phagocytosis of bacteria, fungi, and
parasites by macrophages (11, 17, 45, 47). Given the role of
SNARE proteins in regulating secretory and endocytic pathways,
CSF-1 could potentially modulate the immune functions of mac-
rophages by governing the expression, localization, and/or activity
of SNARE proteins. The Qa-SNARE protein syntaxin 7 (Stx7),
which interacts with Q-SNAREs Vti1b and Stx8 and the
R-SNARE vesicle-associated membrane protein 8 (VAMP8),
regulates late endosome fusion (3, 43). Stx7 has also been impli-
cated in phagocytosis (12) and TNF secretion (37, 38) by macro-
phages. Therefore, we investigated the effects of CSF-1 on Stx7 in
macrophages. The findings presented indicate that CSF-1 regu-
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lates Stx7 expression and function and suggest that CSF-1 may
indeed modulate the effector functions of macrophages, at least in
part, via its ability to regulate Stx7.
MATERIALS AND METHODS
Reagents. Cell culture medium and supplements, fetal calf serum, SuperScript
III reverse transcriptase, precast sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) gels, and anti-V5 antibodies were from Invitrogen. Pfu
DNA polymerase and restriction enzymes were supplied by Promega. Precast
Criterion gels and isoelectric focusing strips (pH 3 to 10) were obtained from
Bio-Rad. The Stx7 and 18S rRNA real-time PCR probe sets were obtained from
ABI. The affinity-purified rabbit polyclonal anti-Stx7 and anti-VAMP8 antibod-
ies were as described previously (34), while the mouse monoclonal anti-Stx8 and
anti-Vti1b antibodies were purchased from BD Biosciences. Anti-phospho-
Erk1/2, anti-phospho-Akt, and anti-Akt antibodies were from Cell Signaling
Technology. The anti-Erk2 and anti-CSF-1 receptor (C-20) antibodies were
provided by Santa Cruz Biotechnology Inc. Protein G-Sepharose, enhanced
chemiluminescence reagents, and [32P]orthophosphate (10 mCi/ml) were pro-
vided by GE Healthcare, while Complete protease inhibitors were obtained from
Roche Biochemicals. The protein kinase C (PKC) inhibitors GF109203X and
Go¨6983, Akt inhibitors Akt VIII and Akt X, and phosphatidylinositol (PI)
3-kinase inhibitors wortmannin and LY294002 were from Calbiochem.
Mouse bone marrow-derived macrophages. The use of mice in this study was
approved by the Melbourne Health Animal Ethics Committee. Bone marrow-
derived macrophages were obtained by culturing bone marrow cells from 6- to
8-week-old, female C57BL/6 mice in Dulbecco’s modified Eagle’s medium sup-
plemented with 5,000 U/ml recombinant CSF-1, 10% fetal calf serum, 100 U/ml
penicillin, 100 g/ml streptomycin, and 2 mM GlutaMax-1 for 6 to 7 days at 37°C
in a humidified atmosphere of 5% CO2 (27).
Real-time PCR analysis of gene expression. Total RNA was isolated with an
RNeasy Mini kit (Qiagen) and then reverse transcribed using SuperScript III
reverse transcriptase (Invitrogen). Quantitative PCR was performed using an
ABI PRISM 7900HT sequence detection system and predeveloped TaqMan
probe/primer combinations for mouse Stx7 and 18S rRNA from ABI. Threshold
cycle numbers were transformed using the CT and relative value method as
described by the manufacturer.
Cell lysis. Macrophages were lysed directly in tissue culture dishes with NP-40
lysis buffer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1% Nonidet
P-40, 10% glycerol, 1 mM sodium orthovanadate, 0.1 mM sodium molybdate, 10
mM NaF, 10 mM -glycerophosphate, and Complete protease inhibitors) for 30
to 60 min on ice. The lysates were clarified by centrifugation at 13,000  g for 10
min at 4°C and the protein concentrations of the supernatants then measured
with a Bio-Rad protein assay kit. The cell lysates were either used immediately
or stored at 70°C.
SDS-PAGE, Western blotting, and immunoprecipitation. One-dimensional
SDS-PAGE was performed according to standard procedures using 10% and
14% SDS-PAGE gels. For two-dimensional SDS-PAGE, isoelectric focusing
(IEF) strips (pH 3 to 10; linear, 11 cm) were passively rehydrated in 8 M urea,
0.5% Triton X-100, 0.5% Pharmalytes (Bio-Rad), and 10 mM dithiothreitol
(DTT) overnight at room temperature. Cell lysates were first concentrated using
Centricon microconcentrators (Millipore Corp.), and then aliquots of the con-
centrated lysates (containing 400 g of protein) were diluted with IEF sample
solution (8 M urea, 50 mM DTT, 0.2% Pharmalytes, 4% 3-[(3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate and 0.002% bromophenol blue). The
samples were absorbed into IEF strips and IEF performed for 30,000 V  h at
20°C using a Protean IEF cell (Bio-Rad). The focused IEF strips were stored at
20°C overnight prior to resolution in the second dimension. The IEF strips were
equilibrated in 0.5 M Tris (pH 8.8), 6 M urea, 2% SDS, 20% glycerol, and 2%
DTT for 15 min before being loaded onto 10% Criterion precast gels, which were
subjected to electrophoresis for 2 h at 100 V. The separated proteins were then
transferred to polyvinylidene difluoride (PVDF) membranes and the membranes
Western blotted with anti-Stx7 antibodies. For immunoprecipitation assays, ali-
quots of cell lysate (containing 500 to 1,000 g protein) were precleared with
protein G-Sepharose beads for 1 h at 4°C with mixing. The mixtures were then
centrifuged at 13,000  g for 5 min at 4°C and the cleared supernatants retained.
One to two micrograms of the appropriate antibody was added to the superna-
tants and the samples incubated for 4 h at 4°C with mixing. Immune complexes
were captured by the addition of protein G-Sepharose and incubating for an
additional 1 h at 4°C with mixing. Following four washes with lysis buffer, the
immunoprecipitates were subjected to Western blotting.
Metabolic labeling and phosphoamino acid analysis. Macrophages were met-
abolically labeled with [32P]orthophosphate by incubating the cells in phosphate-
free Dulbecco’s modified Eagle’s medium supplemented with [32P]orthophos-
phate (4 mCi/6-cm dish) for 6 h. Stx7 was immunoprecipitated from lysates of
labeled macrophages, subjected to SDS-PAGE, and then transferred to a PVDF
membrane. Following exposure to X-ray film, Stx7 bands were excised and the
pieces of membrane washed extensively with water prior to being hydrolyzed in
6 M HCl for 90 min at 100°C. The phosphoamino acid contents of the hydroly-
sates were determined by one-dimensional high voltage electrophoresis on cel-
lulose-coated thin-layer chromatography plates as previously described (10).
Expression vectors and mutagenesis. A mammalian expression vector encod-
ing an N-terminal V5-tagged form of mouse Stx7 (i.e., pEF-V5-Stx7) was created
by PCR using the plasmid pcDNA-HA-Stx7 (34) as the template and the primers
F1 (5-ACG CGT TCT TAC ACT CCG GGG ATT GGT GGG GAC TCT-3)
and R1 (5-ACG CGT TCA GCC TTT CAG TCC CCA TAC GAT GAG
ACA-3). The PCR product generated was digested with MluI and cloned into
pEF-BOS-V5. The expression vector pEF-V5-Stx7S/A, in which Ser-125, Ser-
126, and Ser-129 in Stx7 are replaced by alanine residues, was created by over-
lapping PCR using primers F1 and R-mutagenic 1 (5-GG AAA ACC ACC CGC
TAC CCT GGC GGC GGC TCG CAC TCG AGC-3) and F-mutagenic 1
(5-GCT CGA GTG CGA GCC GCC GCC AGG GTA GCG GGT GGT TTT
CC-3) and R1. The expression vector pEF-V5-Stx7S/E, in which Ser-125, Ser-
126, and Ser-129 in Stx7 are replaced by glutamic acid residues, was created by
overlapping PCR using primers F1 and R-mutagenic 2 (5-AGG AAA ACC
ACC CTC TAC CCT CTC TTC GGC TCG CAC TCG AGC-3) and F-muta-
genic 2 (5-GCT CGA GTG CGA GCC GAA GAG AGG GTA GAG GGT GGT
TTT CCT-3) and R1. The inserts from pEF-V5-Stx7, pEF-Stx7S/A, and pEF-
V5-Stx7S/E were subsequently excised with XbaI and cloned into the retroviral
vector pMX-pie (40).
Retroviral transduction of bone marrow cells. Replication-defective, ecotropic
retroviruses expressing V5-tagged Stx7 (or mutants thereof) were generated by
transfecting the BOSC23 packaging cell line (41) with the appropriate pMX-pie-
based V5-Stx7 construct. Retroviral supernatants were harvested 48 h later,
filtered through a 0.45-m syringe filter, and supplemented with 10 mM HEPES
(pH 7.1) and 8 g/ml Polybrene. The viral supernatants were then used to
transduce mouse bone marrow cells by spin infection (57). C57BL/6 bone mar-
row cells, which had been cultured for 2 days in the presence of CSF-1, were
seeded in 24-well tissue culture plates (2  106 cells per well) and the plates
centrifuged at 500  g for 5 min at 30 to 37°C. The growth medium was removed
and replaced with 2 ml of retroviral supernatant. The plates were then centri-
fuged at 1,500  g for 90 min at 30 to 37°C, after which the viral supernatants
were replaced with fresh growth medium containing CSF-1. A second round of
spin infection was performed 24 h later. The cells were then cultured in the
presence of CSF-1 until a homogenous population of bone marrow-derived
macrophages was obtained (typically 4 to 5 days).
RESULTS
CSF-1 upregulates Stx7 expression in macrophages. Given
that CSF-1 can enhance phagocytosis, pinocytosis, and cytokine
secretion by macrophages (11, 13, 24, 30, 39, 44, 50), we examined
the effect of CSF-1 on the expression levels of Stx7, a Qa-SNARE
protein that has been reported to play a role in these processes (9,
12, 38). Real-time PCR analysis revealed that Stx7 mRNA levels
were upregulated as early as 2 h following the stimulation of
mouse bone marrow-derived macrophages with CSF-1 and max-
imally induced (3- to 4-fold increase) by around 8 h (Fig. 1A).
Stx7 mRNA levels declined slightly thereafter but remained
above prestimulus levels for at least a further 16 h (Fig. 1A). In
order to confirm that the CSF-1-induced upregulation of Stx7
gene expression resulted in a corresponding increase in the pro-
tein levels of Stx7, lysates of macrophages that had been stimu-
lated with CSF-1 for up to 24 h were subjected to Western blot-
ting with an anti-Stx7 antibody. CSF-1 induced an approximately
twofold increase in Stx7 protein levels by 12 h poststimulation
(Fig. 1B). Stx7 is known to form an endosomal SNARE complex
with three other SNARE proteins, namely, Vti1b (a Qb-
SNARE), Stx8 (a Qc-SNARE), and the R-SNARE VAMP8, to
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mediate membrane fusion between late endosomes (3, 43).
Therefore, the ability of CSF-1 to regulate the expression of Stx8,
Vti1b, and VAMP8 was also investigated. While Stx8 expression
was unaffected by CSF-1, an increase in Vti1b expression was
detected as early as 2 h post-CSF-1 stimulation (Fig. 1B). Maxi-
mal upregulation of Vti1b expression (2.5- to 3-fold) occurred
by around 8 to 12 h poststimulation (Fig. 1B). VAMP8 protein
expression was also upregulated approximately threefold by
CSF-1 and remained elevated for at least 24 h (Fig. 1B).
CSF-1 induces serine phosphorylation of Stx7. CSF-1 stim-
ulation of macrophages also appeared to cause a slight reduc-
tion in the electrophoretic mobility of Stx7 (Fig. 1B). To
examine further this apparent effect of CSF-1 on Stx7, CSF-1-
deprived macrophages were subjected to acute stimulation
with CSF-1 (i.e., for up to 60 min); lysates of the cells were then
analyzed by Western blotting. A decrease in the electro-
phoretic mobility of Stx7 was detected as early as 5 min post-
CSF-1 stimulation, with the change in mobility evident for at
least 60 min (Fig. 2A). When SDS-PAGE conditions were
optimal, it was possible to detect at least three to four isoforms
of Stx7 in lysates of CSF-1-stimulated macrophages (Fig. 2A).
Akt and Erk1/2 activation preceded the CSF-1-induced reduc-
tion in the electrophoretic mobility of Stx7, while degradation
of the CSF-1 receptor temporally correlated with the effects of
CSF-1 on Stx7 (Fig. 2A). The changes in the electrophoretic
properties of Stx7 suggested that Stx7 may have become phos-
phorylated. Antiphosphotyrosine Western blotting of anti-Stx7
immunoprecipitates failed to reveal detectable CSF-1-induced
tyrosine phosphorylation of Stx7 (data not shown), thus sug-
gesting that Stx7 may have become phosphorylated on serine
FIG. 1. Regulation of Stx7 expression by CSF-1. (A) Mouse bone
marrow-derived macrophages were deprived of CSF-1 for 16 h before
being stimulated with CSF-1 for the time indicated. Total RNA was
then extracted and reverse transcribed into cDNA, which was then
subjected to quantitative real-time PCR. 18S rRNA was used as the
internal control. Stx7 mRNA levels are relative to its expression in the
absence of CSF-1, which was given an arbitrary value of 1.0. Stx7
mRNA levels (mean 	 standard error) at each time point were mea-
sured in triplicate, and the data are representative of three experi-
ments. (B) Macrophages were cultured as for panel A and cell lysates
subsequently subjected to Western blotting with the indicated antibod-
ies. The membrane was also probed with an antiactin antibody to
assess loading. The positions of molecular mass markers (in kDa) are
indicated on the right. 
-Stx7, anti-Stx7; other antibodies are similarly
indicated.
FIG. 2. CSF-1-induced phosphorylation of Stx7 in macrophages. (A) Mouse bone marrow-derived macrophages were deprived of CSF-1 for
16 h before being stimulated with CSF-1 for the time indicated. The cells were then lysed and the lysates subsequently subjected to Western blotting
with the indicated antibodies. The positions of molecular mass markers (in kDa) and the different Stx7 isoforms (arrows) are indicated on the right.

-Stx7, anti-Stx7; other antibodies are similarly indicated. (B and C) Macrophages that had been metabolically labeled with [32P]orthophosphate
were stimulated with CSF-1 for 15 min and then lysed. (B) Stx7 was immunoprecipitated from the lysates using anti-Stx7 antibodies and the
immunoprecipitates subsequently subjected to autoradiography (upper panel) or Western blotting with an anti-Stx7 antibody (lower panel).
(C) Stx7 that had been immunoprecipitated from the [32P]orthophosphate-labeled macrophages in panel B was excised from the PVDF membrane
and subjected to phosphoamino acid analysis. The positions of phosphoamino acid standards (pSer, phosphoserine; pThr, phosphothreonine; pTyr,
phosphotyrosine) are indicated on the right. (D) Macrophages were deprived of CSF-1 for 16 h before being stimulated with CSF-1 for 15 min
and then lysed in the absence of phosphatase inhibitors. Aliquots of the lysates were incubated with CIP or in reaction buffer alone for 30 min at
37°C. The lysates were then subjected to Western blotting with an anti-Stx7 antibody. (E) Lysates of macrophages that had been left unstimulated
or which had been stimulated with CSF-1 for 15 min were subjected to two-dimensional SDS-PAGE analysis followed by Western blotting with
an anti-Stx7 antibody.
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and/or threonine residues in response to CSF-1. This idea was
tested by metabolically labeling macrophages with [32P]-
orthophosphate prior to stimulating them with CSF-1 and im-
munoprecipitating Stx7. Analysis of the anti-Stx7 immunopre-
cipitates revealed that although Stx7 was phosphorylated in the
absence of CSF-1, CSF-1 stimulation led to a marked increase
in the phosphorylation of Stx7 (Fig. 2B). Phosphoamino acid
analysis revealed that Stx7 from both unstimulated and CSF-
1-stimulated macrophages was phosphorylated exclusively on
serine residues (Fig. 2C). To establish if phosphorylation of
Stx7 accounted for the appearance of the different isoforms
detected by Western blotting, lysates of macrophages that had
been stimulated with CSF-1 or had been left unstimulated
were treated with calf intestinal alkaline phosphatase (CIP).
As shown in Fig. 2D, the more slowly migrating isoforms of
Stx7 largely disappeared when the cell lysates were treated
with CIP. The effects of CSF-1 on the electrophoretic proper-
ties of Stx7 were also examined by two-dimensional SDS-
PAGE. Stx7 from macrophages that had been deprived of
CSF-1 exhibited a range of pI values but could generally be
divided into two major populations (Fig. 2E); however, only a
single population of Stx7, which had a higher pI, was detected
following CSF-1 stimulation (Fig. 2E). Phosphorylated pro-
teins are more acidic than their nonphosphorylated counter-
parts, and thus, the increase in pI was unexpected. Further-
more, treating the lysates with CIP prior to two-dimensional
SDS-PAGE did not abrogate the CSF-1-induced increase in pI
(data not shown). Therefore, the different Stx7 “isoforms”
detected by two-dimensional SDS-PAGE may have repre-
sented different Stx7 complexes rather than differentially phos-
phorylated Stx7. Supporting this contention is the fact that
urea, which was used during the isoelectric-focusing step to
promote protein denaturation, has previously been used to
stabilize Stx7-Vti1b-Stx8 complexes in order to allow their
analysis by ion-exchange chromatography (2).
CSF-1 stimulation enhances the binding of Stx7 to its part-
ner SNARE proteins. Given that Stx7 regulates vesicles traf-
ficking in concert with other SNARE proteins (e.g., Vti1b,
Stx8, and VAMP8) (3, 34, 43), the effects of CSF-1 on the
interaction of Stx7 with other endosomal SNARE proteins
were examined. Vti1b, Stx8, and VAMP8 coimmunoprecipi-
tated with Stx7 from CSF-1-deprived macrophages; however,
acute CSF-1 stimulation resulted in a two- to threefold in-
crease in their coimmunoprecipitation with Stx7 (Fig. 3A and
B). The coimmunoprecipitation of Vti1b, Stx8, and VAMP8
with Stx7 was specific since they were not detected in immu-
noprecipitates using an irrelevant control antibody (Fig. 3A).
Reciprocal coimmunoprecipitation experiments with anti-
Vti1b (Fig. 3C and D) and anti-Stx8 (Fig. 3E and F) antibodies
likewise demonstrated increased complex formation between
Stx7, Vti1b, Stx8, and VAMP8 in response to CSF-1 stimula-
tion.
Bioinformatics analysis of potential phosphorylation sites
in Stx7. In order to identify the serine residue(s) in Stx7 that
underwent CSF-1-induced phosphorylation, the amino acid se-
quence of Stx7 was first subjected to bioinformatics analysis.
ClustalW-based sequence alignment (53) of mouse Stx7 (Uni-
ProtKB/Swiss-Prot accession number 070439) with those of the
rat (accession number 070257), human (accession number
015400), and ape (accession number Q5R602) Stx7 proteins
identified 17 serine residues that were evolutionarily conserved
across all 4 species (Fig. 4A). Of note were the seven conserved
serine residues (Ser-125, Ser-126, Ser-129, Ser-136, Ser-137,
Ser-144, and Ser-147) at the C-terminal end of the Hc domain
and in the “linker” region connecting the Hc domain and the
SNARE domain, as well as the four conserved serine residues
(Ser-173, Ser-174, Ser-205, and Ser-225) in the SNARE do-
main (Fig. 4A). Submission of the mouse Stx7 amino acid
sequence to the NetPhos server (www.cbs.dtu.dk/services
/NetPhos/) (7) identified a number of putative serine phosphor-
FIG. 3. Effects of CSF-1 on Stx7 SNARE complexes in macrophages. Mouse bone marrow-derived macrophages were deprived of CSF-1 for
16 h before being stimulated with CSF-1 for 15 min. Following cell lysis, Stx7 (A and B), Vti1b (C and D), and Stx8 (E and F) were
immunoprecipitated from the lysates using anti-Stx7, anti-Vti1b, and anti-Stx8 antibodies (
-Stx7, 
-Vti1b, and 
-Stx8), respectively. Lysates were
also immunoprecipitated with irrelevant control antibodies. (A, C, and E). The immunoprecipitates were subsequently subjected to Western
blotting with the indicated antibodies. (B, D, and F) Quantified data are presented as the increase in SNARE protein binding following CSF-1
stimulation relative to that in unstimulated macrophages. Data represent the means (	 standard errors) of at least three experiments.
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ylation sites. Among these sites, Ser-125, Ser-126, Ser-129,
Ser-173, and Ser-234 received the highest scores (Fig. 4B). The
NetPhosK 1.0 server (www.cbs.dtu.dk/services/NetPhosK/),
which predicts phosphorylation sites in proteins for specific
protein kinases (8), identified Ser-20 and Ser-125 as likely sites
of phosphorylation by PKC (Fig. 4C). Similarly, Ser-126 was
identified as a potential phosphorylation site for Akt (Fig. 4C).
Activation of PKC triggers phosphorylation of Stx7. Given
the above findings and the fact that CSF-1 has been reported
to trigger the activation of PKC in macrophages (23, 56), we
tested whether treatment of macrophages with the PKC acti-
vating agent phorbol myristate acetate (PMA) resulted in the
phosphorylation of Stx7. Figure 5A shows that PMA induced a
rapid decrease in the electrophoretic mobility of Stx7, suggest-
ing that Stx7 had indeed undergone phosphorylation upon
PKC activation. PMA stimulation did not result in Akt activa-
tion (data not shown), but it did lead to the rapid and transient
FIG. 4. Predicted serine phosphorylation sites in Stx7. (A) The amino
acid sequences of mouse, rat, human, and ape Stx7 were aligned using the
ClustalW algorithm. Serine residues that are conserved across all four
species are indicated with inverted arrows. Ser-125, Ser-126, and Ser-129
are shaded in gray. The Ha, Hb, Hc, SNARE, and transmembrane (TM)
domains are boxed. (B) The amino acid sequence of mouse Stx7 was
analyzed using the NetPhos 2.0 software program. Predicted serine phos-
phorylation sites in Stx7 and their corresponding probability scores are
shown. (C) The amino acid sequence of mouse Stx7 was analyzed using
the NetPhosK 1.0 software program. Predicted serine phosphorylation
sites in Stx7, the protein kinase predicted to phosphorylate the site, and
their corresponding probability scores (0.50) are shown.
FIG. 5. Phosphorylation of Stx7 by PKC in macrophages.
(A) Mouse bone marrow-derived macrophages were deprived of
CSF-1 for 16 h before being stimulated with 100 nM PMA for the time
indicated. The cells were then lysed and the lysates subsequently sub-
jected to Western blotting with the indicated antibodies. The different
Stx7 isoforms are indicated by arrows on the right. 
-Stx7, -pErk1/2,
and -Erk2 represent anti-Stx7, -pErk1/2, and -Erk2. (B) Macrophages
were deprived of CSF-1 for 16 h before being treated with 0.1%
dimethyl sulfoxide, 5 M GF109203X, or 1 M Go¨6983 for 30 min.
The macrophages were stimulated with CSF-1 for 15 min and then
lysed. The lysates were subsequently subjected to Western blotting
with the indicated antibodies (shown as in panel A). (C) Macrophages
were deprived of CSF-1 for 16 h before being treated with 0.1%
dimethyl sulfoxide, 5 M GF109203X, or 1 M Go¨6983 for 30 min.
The macrophages were stimulated with PMA for 15 min and then
lysed. The lysates were subsequently subjected to Western blotting
with the indicated antibodies.
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activation of Erk1/2 (Fig. 5A). To determine whether CSF-1-
induced phosphorylation of Stx7 involved PKC, the effects of
the PKC inhibitors GF109203X (54) and Go¨6983 (20) on the
electrophoretic mobility of Stx7 were examined. GF109203X
partially blocked the CSF-1-induced change in Stx7 mobility,
whereas Go¨6983 was without effect (Fig. 5B). The efficacy of
the PKC inhibitors was confirmed by demonstrating their ca-
pacity to block PMA-induced Erk1/2 activation (Fig. 5C). The
ability of GF109203X to partially suppress the CSF-1-induced
phosphorylation of Stx7 was not a consequence of the inhibitor
impairing Akt activation by CSF-1 (Fig. 5B). These observa-
tions suggested that in addition to PKC, another serine/threo-
nine kinase(s) also contributed to the CSF-1-induced phosphor-
ylation of Stx7.
Regulation of Stx7 phosphorylation by Akt and PI 3-kinase.
Bioinformatics analysis of Stx7 also indicated that Akt, which is
activated in response to CSF-1 (28), may also phosphorylate
Stx7, particularly at Ser-126 (Fig. 4C). In order to establish if
Akt activity was required for the CSF-1-induced phosphoryla-
tion of Stx7, macrophages were treated with the Akt inhibitors
Akt VIII (6) and Akt X (52) prior to their stimulation with
CSF-1. As shown in Fig. 6A, Akt inhibitor VIII partially sup-
pressed the CSF-1-induced phosphorylation of Stx7 while com-
pletely blocking Akt activation. In contrast, Akt inhibitor X
had no apparent affect on Stx7 phosphorylation and only par-
tially blocked the activation of Akt in response to CSF-1 (Fig.
6A). Given that the activation of Akt is dependent on PI
3-kinase activity, the effects of the PI 3-kinase inhibitors
LY294002 (60) and wortmannin (5) on the CSF-1-induced
phosphorylation of Stx7 were also examined. Both PI 3-kinase
inhibitors markedly suppressed Stx7 phosphorylation (Fig.
6A). Inhibitors of p70S6 kinase, MEK, p38 MAP kinase, and
Src family kinases had no effect on the CSF-1-induced phos-
phorylation of Stx7 (data not shown). Because the activation of
PI 3-kinase can lead to the activation of various PKC isoforms
(32) and to the activation of Akt, the combined effects of the
PKC inhibitor GF109203X and Akt inhibitor VIII on Stx7
phosphorylation were assessed. When used in combination, the
two inhibitors reduced the CSF-1-induced phosphorylation of
Stx7 to an extent that was largely comparable to that achieved
with the PI 3-kinase inhibitor LY294002 (Fig. 6B). Thus, the
CSF-1-induced phosphorylation of Stx7 is most likely mediated
via both PKC and Akt in response to the activation of PI
3-kinase.
Regulation of the interaction of Stx7 with other SNARE
proteins by PI 3-kinase. PI 3-kinase-dependent phosphoryla-
tion of Stx7 by PKC and Akt may represent an important
mechanism to regulate the assembly of endosomal SNARE
complexes. Therefore, the effect of the PI 3-kinase inhibitor
LY294002 on the binding of Stx7 to Vti1b, Stx8, and VAMP8
was examined. The ability of CSF-1 to enhance the binding of
Stx7 to Vti1b was blocked when the macrophages were pre-
treated with LY294002 (Fig. 7A and B). The enhanced inter-
action between Stx7, Vti1b, Stx8, and VAMP8 in response to
CSF-1 and the sensitivity of this response to LY294002 were
confirmed by coimmunoprecipitation assays using antibodies
against Stx8 and Stx7 (Fig. 7C to E). Western blotting of the
cell lysates revealed that LY294002 had not affected the ex-
pression level of Stx7, Vti1b, or VAMP8 (Fig. 7F). Together,
these findings suggest that the PI 3-kinase-dependent phos-
phorylation of Stx7 positively regulates its binding to partner
SNARE proteins. However, we cannot exclude the possibility
that the inhibitory effects of the PI 3-kinase inhibitor on
SNARE complex assembly could also have been due to the
impaired trafficking of the SNARE proteins to late endosomes/
lysosomes.
Mutation of Ser-125, Ser-126, and Ser-129 abrogates CSF-
1-induced phosphorylation of Stx7. It has recently been re-
ported that Ser-125, Ser-126, and Ser-129 in Stx7, which we
identified as potential phosphorylation sites for PKC and Akt
(Fig. 4C), are phosphorylated in vivo (59). To establish if these
serine residues represent the major CSF-1-induced phosphor-
ylation sites in Stx7, mutant forms of Stx7, in which Ser-125,
Ser-126, and Ser-129 were replaced with alanine or the phos-
phomimetic, glutamic acid (see Fig. 8A), were expressed in
macrophages via retroviral transduction. Mutation of Ser-125,
Ser-126, and Ser-129 to alanine largely abolished the ability of
CSF-1 to induce the appearance of higher-molecular-mass iso-
forms of Stx7 (Fig. 8B). Furthermore, the Stx7 serine-to-ala-
nine mutant (V5-Stx7S/A) appeared to exhibit a slightly faster
electrophoretic mobility than V5-Stx7, even in the absence of
CSF-1 (Fig. 8B). When the same serine residues were mutated
to glutamic acid (V5-Stx7S/E), Stx7 exhibited a reduced elec-
trophoretic mobility (Fig. 8B). This reduction in mobility was
not a consequence of increased basal levels of activated Akt in
FIG. 6. Effects of Akt and PI 3-kinase inhibitors on CSF-1-induced
phosphorylation of Stx7 in macrophages. (A) Mouse bone marrow-
derived macrophages were deprived of CSF-1 for 16 h before being
treated with 0.1% dimethyl sulfoxide, 10 M Akt-VIII, 5 M Akt-X,
10 M LY294002, or 100 nM wortmannin for 30 min. The macro-
phages were stimulated with CSF-1 for 15 min and then lysed. The
lysates were subsequently subjected to Western blotting with the indi-
cated antibodies (anti-Stx7, anti-pAkt, and anti-Akt). The different
Stx7 isoforms are indicated by arrows on the right. (B) Macrophages
were deprived of CSF-1 for 16 h before being treated with 0.1%
dimethyl sulfoxide, 10 M Akt VIII, 5 M GF109203X (GFX), 10 M
Akt VIII and 5 M GF109203X together, or 10 M LY294002 for 30
min. The macrophages were stimulated with CSF-1 for 15 min and
then lysed. The lysates were subsequently subjected to Western blot-
ting with the indicated antibodies.
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macrophages expressing V5-Stx7S/E (Fig. 8B). Likewise, the
inability of CSF-1 to induce a decrease in the mobility of
V5-Stx7S/A was not due to a failure of CSF-1 to activate Akt
(Fig. 8B). The contribution of Ser-125, Ser-126, and Ser-129 to
Stx7 total phosphorylation was assessed by metabolically label-
ing retrovirally transduced macrophages with [32P]orthophos-
phate. As was the case for endogenous Stx7 (Fig. 2B), V5-Stx7
was phosphorylated in the absence of CSF-1 but underwent
further phosphorylation upon CSF-1 stimulation (Fig. 8C).
V5-Stx7S/A exhibited a lower level of basal phosphorylation
than did V5-Stx7, and stimulation with CSF-1 did not result in
any increase in its phosphorylation (Fig. 8C). The extent of
V5-Stx7S/E phosphorylation, both in the absence and presence
of CSF-1, was comparable to that of V5-Stx7 from unstimu-
lated macrophages (Fig. 8C). Thus, Ser-125, Ser-126, and/or
Ser-129 represent the major CSF-1-induced phosphorylation
sites in Stx7.
Ser-125, Ser-126, and/or Ser-129 regulate the CSF-1-depen-
dent binding of Stx7 to other SNARE proteins. The impor-
tance of the phosphorylation of Ser-125, Ser-126, and/or Ser-
129 for the binding of Stx7 to partner SNARE proteins was
evaluated by immunoprecipitating the mutant forms of Stx7
from retrovirally transduced macrophages. Mutation of Ser-
125, Ser-126, and Ser-129 to glutamic acid resulted in a three-
to fourfold increase in the CSF-1-independent binding of
Vti1b and VAMP8 to Stx7 (Fig. 9A and B). In contrast, no
increase in CSF-1-independent binding of Vti1b and VAMP8
occurred when Ser-125, Ser-126, and Ser-129 were mutated to
alanine (Fig. 9A and B). Furthermore, CSF-1 failed to enhance
the binding of Vti1b and VAMP8 to V5-Stx7S/A (Fig. 9A).
Although V5-Stx7S/E exhibited a higher level of CSF-1-inde-
pendent Vti1b and VAMP8 binding than V5-Stx7, the binding
of Vti1b and VAMP8 to V5-Stx7S/E was not enhanced further
by CSF-1 (Fig. 9A). On the basis of these findings, it is sug-
gested that the PI 3-kinase-dependent phosphorylation of Stx7
on Ser-125, Ser-126, and/or Ser-129 is a key regulatory event in
the binding of Stx7 to its SNARE partners in macrophages.
DISCUSSION
Previous studies, including our own, have shown that Stx7
forms an endosomal SNARE complex with Vti1b, Stx8, and
VAMP8 to mediate late endosome/lysosome fusion (3, 34, 43).
In macrophages, Stx7 has been detected on mature phago-
somes (12); it has also been shown to be a component of a
novel SNARE complex that mediates the trafficking of the key
inflammatory cytokine TNF to the plasma membrane (38).
Given that CSF-1 regulates phagocytosis, pinocytosis, and cy-
tokine secretion in macrophages (11, 13, 24, 30, 44, 50), we
propose that the regulation of Stx7 expression and function by
CSF-1 contributes to its regulatory effects on at least some of
these effector functions.
Stx7 expression was upregulated, at both the mRNA and
protein levels, by CSF-1 in mouse bone marrow-derived mac-
rophages (Fig. 1). Vti1b and VAMP8 expression was also up-
regulated; however, the expression levels of Stx8 appear to be
unaffected by CSF-1. LPS has been reported to increase Vti1b,
Stx6, and VAMP3 expression in macrophages; moreover, their
LPS-induced upregulation was necessary for efficient TNF se-
cretion (37, 38). Gamma interferon (IFN-), which heightens
the inflammatory response of macrophages to pathogens (e.g.,
increases cytokine secretion), also upregulates the expression
of Vti1b, Stx6, and VAMP3 (37, 38). Whether the effects of
CSF-1, LPS, and IFN- on SNARE protein expression are
identical but perhaps additive, or just overlapping, is still to be
established. Nonetheless, our findings, together with those of
Stow and colleagues (37, 38), suggest that the regulatory effects
of growth factors (e.g., CSF-1) and cytokines (e.g., IFN-) on
FIG. 7. Effects of PI 3-kinase inhibition on Stx7 SNARE complexes in macrophages. Mouse bone marrow-derived macrophages were deprived
of CSF-1 for 16 h before being treated with 0.1% dimethyl sulfoxide or 10 M LY294002 for 30 min. The macrophages were stimulated with CSF-1
for 15 min and then lysed. Vti1b (A and B), Stx8 (C and D), and Stx7 (E) were subsequently immunoprecipitated (IP) from the cell lysates
with anti-Vti1b (
-Vti1b), anti-Stx8 (
-Stx8), and anti-Stx7 (
-Stx7) antibodies, respectively, and then Western blotted with the indicated
antibodies. (B and D) Quantified data are presented as the increase in SNARE protein binding following CSF-1 stimulation relative to that in
unstimulated macrophages. Data represent the means (	 standard errors) of three experiments. (F) Western blotting of cell lysates with the
indicated antibodies.
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macrophages are likely to be mediated, at least in part, via
their ability to regulate the expression of the SNARE proteins
that are required for specific effector functions (e.g., cytokine
secretion).
Little is known about how the binding of Stx7 to its partner
SNARE proteins is regulated. However, the data we have
presented here suggest that phosphorylation of Stx7 is a key
regulatory event in the assembly of endosomal SNARE com-
plexes. Bioinformatics analysis identified Ser-125, Ser-126, and
Ser-129 as likely sites for phosphorylation. In support of this
contention, a recent mass spectrometry-based analysis of phos-
phorylation sites in proteins from mouse liver identified Ser-
125, Ser-126, and Ser-129 as in vivo phosphorylation sites in
Stx7 (59). Our analysis predicted that the phosphorylation of
these sites was likely to be mediated by PKC and Akt. While
pharmacologic inhibitors of PKC and Akt individually sup-
pressed the CSF-1-induced phosphorylation of Stx7, the extent
of suppression was not as great as that achieved with a PI
3-kinase inhibitor (e.g., LY294002). However, when the PKC
and Akt inhibitors were used in combination, they were as
effective as the PI 3-kinase inhibitor. Based on these findings,
we propose that PKC and Akt are largely responsible for
mediating the CSF-1-induced phosphorylation of Stx7 in re-
sponse to PI 3-kinase activation, potentially via the PI 3-kinase
target, phosphoinositide-dependent kinase 1 (32).
The CSF-1-induced phosphorylation of Ser-125, Ser-126,
and/or Ser-129, which are located at the end of the Habc
domain and at the start of the “linker” connecting the Habc
and SNARE domains in Stx7, appears to positively regulate
the binding of Stx7 to its SNARE partners (e.g., Vti1b and
VAMP8). Notably, though, the phosphorylation of Ser-125,
Ser-126, and/or Ser-129 is not obligatory for the binding of Stx7
to its partner SNARE proteins, since a Stx7 mutant (i.e., Stx7S/
A), in which these amino acids had been replaced with alanine
residues, could still bind Vti1b and VAMP8. This suggests that
the phosphorylation of Ser-125, Ser-126, and/or Ser-129 in Stx7
regulates the rate of complex assembly between Stx7 and its
partner SNARE proteins and/or the stability of such SNARE
complexes.
The Habc domain of Stx7 has been shown to fold back and
interact intramolecularly with the SNARE domain; SNARE
complex assembly is retarded in this “closed” conformation
(2). However, deletion of the Habc domain releases Stx7 from
FIG. 8. Effects of mutating Ser-125, Ser-126, and Ser-129 on the
CSF-1-induced phosphorylation of Stx7. (A) Schematic representation
of V5-tagged wild-type Stx7 (V5-Stx7) and V5-Stx7 in which Ser-125,
Ser-126, and Ser-129 have been replaced with alanine (V5-Stx7S/A) or
glutamic acid (V5-Stx7S/E). The C-terminal transmembrane anchor
domain is represented by a gray filled box. (B and C) Mouse bone
marrow cells were transduced with retroviruses expressing V5-Stx7,
V5-Stx7S/A, or V5-Stx7S/E or were transduced with a virus containing
the empty vector (EV). The cells were cultured in the presence of
CSF-1 until they differentiated into adherent macrophages. (B) The
macrophages were then deprived of CSF-1 for 16 h before being
stimulated with CSF-1 for 15 min. The cells were lysed and the lysates
subsequently subjected to Western blotting with the indicated antibod-
ies (anti-V5, anti-pAkt, and anti-Akt). (C) Retrovirally transduced
macrophages were metabolically labeled with [32P]orthophosphate be-
fore being stimulated with CSF-1 for 15 min. The cells were then lysed
and the V5-tagged Stx7 proteins immunoprecipitated using anti-V5
antibodies. The immunoprecipitates were subsequently subjected to
autoradiography (upper panel) and Western blotting with an anti-V5
antibody (lower panel).
FIG. 9. Effects of mutating Ser-125, Ser-126, and Ser-129 in Stx7 on
the assembly of Stx7 SNARE complexes. Mouse bone marrow cells
were transduced with retroviruses expressing V5-Stx7, V5-Stx7S/A, or
V5-Stx7S/E or were transduced with a virus containing the empty
vector (EV). The cells were then cultured in the presence of CSF-1
until they differentiated into adherent macrophages. The macrophages
were deprived of CSF-1 for 16 h before being stimulated with CSF-1
for 15 min. (A) The cells were then lysed and the V5-tagged Stx7
proteins immunoprecipitated using anti-V5 (
-V5) antibodies. The
immunoprecipitates were subsequently subjected to Western blotting
with the indicated antibodies (anti-Vti1b [
-Vti1b], anti-VAMP8
[
-VAMP8], and anti-V5). (B) Quantified data are presented as the
increase in the CSF-1-independent binding of Vti1b and VAMP8 to
V5-Stx7S/A and V5-Stx7S/E relative to their binding to V5-Stx7. Data
represent the means (	 standard errors) of three independent exper-
iments.
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this inhibitory constraint and leads to accelerated SNARE
complex assembly (2). The Habc domain of the Qa-SNARE
protein Stx1A also interacts with the SNARE domain to inhibit
SNARE complex assembly (14, 16, 35). While an intramolec-
ular interaction between the Habc and SNARE domains of
Stx7 is likely to contribute to the regulation of endosomal
SNARE complex assembly, how the switching of Stx7 from a
“closed” to an “open” conformation is regulated in vivo has
not been established. Our results suggest that the PI 3-kinase-
dependent phosphorylation of Stx7 by PKC and Akt regulates
the conformational state of Stx7. We propose that phosphory-
lation of Ser-125, Ser-126, and/or Ser-129 in response to PI
3-kinase activation induces a conformational change in Stx7
such that it adopts an “open” conformation in which its
SNARE domain is accessible to bind other SNARE proteins
(Fig. 10), thereby facilitating the assembly of Stx7 SNARE
complexes.
Like Stx7, the Qb-SNARE Vti1b also contains a Habc do-
main; however, unlike Stx7 the Habc and SNARE domains of
Vti1b do not appear to interact intramolecularly to suppress
SNARE complex assembly (2). Consequently, phosphorylation
of Stx7, in particular phosphorylation of Ser-125, Ser-126,
and/or Ser-129, is likely to be a major determinant of the
assembly of Stx7-Vti1b-Stx8 Q-SNARE complexes. Stx7 also
forms a SNARE complex with Vti1b and the Qc-SNARE Stx6
to facilitate the fusion of Golgi-derived vesicles with recycling
endosomes during the intracellular trafficking of TNF in mac-
rophages (38). How Stx7 discriminates between different part-
ner SNARE proteins (e.g., Stx6 versus Stx8) has not been
elucidated. While the subcellular localization of its partner
SNARE proteins, as well as the nature of the cargo to be
transported by the vesicle, is likely to influence which SNARE
proteins Stx7 binds, phosphorylation of Stx7 could potentially
regulate the differential binding of SNARE proteins to Stx7.
Our mutagenesis and metabolic labeling experiments sug-
gested that Ser-125, Ser-126, and Ser-129 represent the major
CSF-1-induced phosphorylation sites in Stx7. However, bioin-
formatics analysis also identified Ser-173 and Ser-234 as pos-
sible phosphorylation sites for PKC. Ser-173 is located near the
start of the SNARE motif, while Ser-234 resides between the
SNARE domain and the hydrophobic C-terminal membrane
anchoring domain. It will clearly be important to establish if
Ser-173 and Ser-234 are bona fide phosphorylation sites and if
their phosphorylation status differentially regulates the binding
of SNARE proteins, such as Stx6 and Stx8, to Stx7.
Stx7 also binds to non-SNARE proteins, such as class C
vacuolar protein sorting (Vps) proteins (e.g., Vps33, a Sec1-
like protein) (29). Class C Vps proteins control the fusion of
late endosomes with lysosomes by regulating SNARE protein
pairing (42, 46). Studies with yeast revealed that the class C
Vps complex binds to unpaired Vam3p (a yeast syntaxin ho-
molog) but not to Vam3p that is bound to its SNARE partners
(46). It is worth noting that the Sec1 protein Munc18 interacts
with and stabilizes the “closed” conformation of Stx1A (14). By
analogy, the phosphorylation state, and hence conformation,
of Stx7 may regulate its interaction with the Sec1-like protein
Vps33.
PI 3-kinase activity is required for a range of vesicular traf-
ficking processes in macrophages (4, 36, 58). The findings pre-
sented here on the regulation of Stx7 and the assembly of
endosomal SNARE complexes by PI 3-kinase may help to
explain, at least in part, the importance of PI 3-kinase activity
for endocytic processes in macrophages. Moreover, the effects
of CSF-1 on Stx7 may provide a mechanism for the regulation
of macrophage effector functions, such as cytokine secretion,
phagocytosis, and macropinocytosis, by CSF-1. Our findings
may also be of relevance to the regulation of CSF-1 signaling.
Endocytosis and lysosomal degradation of activated CSF-1 re-
ceptor is important for controlling CSF-1 signaling and mac-
rophage proliferation (31). There is mounting evidence that
some receptors (e.g., epidermal growth factor receptor) con-
tinue to signal during their transit through the endocytic path-
way (21). The ability of CSF-1 to regulate the expression and
function of the SNARE proteins that control late endosome/
lysosome fusion may therefore represent a novel negative-
feedback mechanism to regulate the duration and magnitude
of CSF-1 signaling.
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